Replies to post #135475 on Biotech Values

[Biowatch]

How many decades has CVM touted Multikine, which has no patent protection?

I realize the CEO pulls down a huge salary, but when do you decide to call it quits and retire?

How many clinical trials can you run without making it to market?

[DewDiligence]

One investing rule that never changes—a folksy shareholder letter from the CEO is soon followed by a financing transaction:

http://finance.yahoo.com/news/CEL-SCI-Corporation-Raise-5-bw-3667798450.html?x=0